Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

GeoVax Labs (GOVX) Invested Capital (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Invested Capital for 16 consecutive years, with $4.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Invested Capital fell 42.3% to $4.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.9 million, a 42.3% decrease, with the full-year FY2024 number at $5.0 million, down 12.4% from a year prior.
  • Invested Capital was $4.9 million for Q3 2025 at GeoVax Labs, up from $2.8 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $31.8 million in Q3 2022 to a low of -$2.3 million in Q2 2024.
  • A 5-year average of $12.7 million and a median of $9.1 million in 2023 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: crashed 113.45% in 2024, then surged 14451.87% in 2025.
  • GeoVax Labs' Invested Capital stood at $4.4 million in 2021, then surged by 509.85% to $26.6 million in 2022, then crashed by 78.33% to $5.8 million in 2023, then fell by 12.4% to $5.0 million in 2024, then decreased by 2.8% to $4.9 million in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Invested Capital are $4.9 million (Q3 2025), $2.8 million (Q2 2025), and $7.9 million (Q1 2025).